Search Results - "Nomeir, A."

Refine Results
  1. 1
  2. 2

    The Pathogenesis of Acute Pulmonary Edema Associated with Hypertension by Gandhi, Sanjay K, Powers, John C, Nomeir, Abdel-Mohsen, Fowle, Karen, Kitzman, Dalane W, Rankin, Kevin M, Little, William C

    Published in The New England journal of medicine (04-01-2001)
    “…It is a clinical paradox that patients hospitalized with congestive heart failure may later be noted to have normal systolic function, as evidenced by a normal…”
    Get full text
    Journal Article
  3. 3

    Permeability of lipophilic compounds in drug discovery using in-vitro human absorption model, Caco-2 by Krishna, Gopal, Chen, Kwang-jong, Lin, Chin-chung, Nomeir, Amin A

    Published in International journal of pharmaceutics (03-07-2001)
    “…Highly lipophilic compounds are often encountered in the early stages of drug discovery. The apparent permeability (Papp) of these compounds in Caco-2 cell…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Development and Validation of an LC-MS-MS Method for the Simultaneous Determination of Sulforaphane and its Metabolites in Rat Plasma and its Application in Pharmacokinetic Studies by Wang, Hu, Lin, Wen, Shen, Guoxiang, Nomeir, Amin A., Khor, Tin-Oo, Kong, Ah-Ng

    Published in Journal of chromatographic science (01-11-2011)
    “…A highly sensitive and simple high-performance liquid chromatographic-tandem mass spectrometric (LC-MS-MS) assay is developed and validated for the…”
    Get full text
    Journal Article
  7. 7

    Estimation of the extent of oral absorption in animals from oral and intravenous pharmacokinetic data in drug discovery by Nomeir, Amin A, Morrison, Richard, Prelusky, Daniel, Korfmacher, Walter, Broske, Lisa, Hesk, David, McNamara, Paul, Mei, Hong

    Published in Journal of pharmaceutical sciences (01-11-2009)
    “…Oral administration is the most desirable route of drug delivery for systemically active drugs. Oral drugs must possess a certain level of oral…”
    Get more information
    Journal Article
  8. 8

    Pharmacokinetics of SCH 56592, a New Azole Broad-Spectrum Antifungal Agent, in Mice, Rats, Rabbits, Dogs, and Cynomolgus Monkeys by NOMEIR, A. A, KUMARI, P, HILBERT, M. J, GUPTA, S, LOEBENBERG, D, CACCIAPUOTI, A, HARE, R, MILLER, G. H, LIN, C.-C, CAYEN, M. N

    Published in Antimicrobial Agents and Chemotherapy (01-03-2000)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  9. 9

    IN VIVO AND IN VITRO EFFICACY OF NIGELLA SATIVA AQUEOUS EXTRACT ON BLASTOCYSTIS HOMINIS by Eida, Omima M, El-Shafei, Hanaa A, Nomeir, Yousra A, El Safhi, Mohammed B

    “…Metronidazole (MTZ) was the most widely accepted treatment for Blastocystis hominis (B. hominis) with high treatment failure rate, resistance and potential…”
    Get more information
    Journal Article
  10. 10

    High-performance liquid chromatographic analysis and stability of anti-tumor agent temozolomide in human plasma by Kim, Hong, Likhari, Paul, Parker, Donald, Statkevich, Paul, Marco, Aliceann, Lin, Chin-Chung, Nomeir, Amin A.

    “…Temozolomide (SCH 52365; TEMODAL™) is an antineoplastic agent with activity against a broad spectrum of murine tumors. This compound is currently marketed in…”
    Get full text
    Journal Article
  11. 11

    Inhibition of CYP3A4 in a Rapid Microtiter Plate Assay Using Recombinant Enzyme and in Human Liver Microsomes Using Conventional Substrates by NOMEIR, Amin A, RUEGG, Charles, SHOEMAKER, Matthew, FAVREAU, Leonard V, PALAMANDA, Jairam R, SILBER, Paul, LIN, Chin-Chung

    Published in Drug metabolism and disposition (01-05-2001)
    “…Cytochrome P450 inhibition studies are performed in the pharmaceutical industry in the discovery stage to screen candidates that may have the potential for…”
    Get full text
    Journal Article
  12. 12

    Higher-throughput screening for Caco-2 permeability utilizing a multiple sprayer liquid chromatography/tandem mass spectrometry system by Fung, Eliza N., Chu, Inhou, Li, Cheng, Liu, Tongtong, Soares, Anthony, Morrison, Richard, Nomeir, Amin A.

    Published in Rapid communications in mass spectrometry (01-01-2003)
    “…In the current drug discovery environment, higher‐throughput analytical assays have become essential to keep pace with the screening demands for drug…”
    Get full text
    Journal Article
  13. 13

    Discovery of MK-8742: An HCV NS5A Inhibitor with Broad Genotype Activity by Coburn, Craig A., Meinke, Peter T., Chang, Wei, Fandozzi, Christine M., Graham, Donald J., Hu, Bin, Huang, Qian, Kargman, Stacia, Kozlowski, Joseph, Liu, Rong, McCauley, John A., Nomeir, Amin A., Soll, Richard M., Vacca, Joseph P., Wang, Dahai, Wu, Hao, Zhong, Bin, Olsen, David B., Ludmerer, Steven W.

    Published in ChemMedChem (01-12-2013)
    “…The NS5A protein plays a critical role in the replication of HCV and has been the focus of numerous research efforts over the past few years. NS5A inhibitors…”
    Get full text
    Journal Article
  14. 14

    Novel in vivo procedure for rapid pharmacokinetic screening of discovery compounds in rats by Cox, Kathleen A., Dunn-Meynell, Kimberly, Korfmacher, Walter A., Broske, Lisa, Nomeir, Amin A., Lin, Chin-Chung, Cayen, Mitchell N., Barr, William H.

    Published in Drug Discovery Today (01-05-1999)
    “…In therapeutic areas aimed at developing an orally administered drug, the pharmacokinetic profile of a drug candidate after oral administration in vivo is…”
    Get full text
    Book Review Journal Article
  15. 15
  16. 16

    Use of high-performance liquid chromatographic and microbiological analyses for evaluating the presence or absence of active metabolites of the antifungal posaconazole in human plasma by Kim, Hong, Kumari, Pramila, Laughlin, Mark, Hilbert, Mary Jane, Indelicato, Stephen R, Lim, Josephine, Lin, Chin-Chung, Nomeir, Amin A

    Published in Journal of Chromatography A (14-02-2003)
    “…Posaconazole (SCH 56592) is a novel broad spectrum triazole antifungal agent that is currently in phase III clinical trials for the treatment of systemic…”
    Get full text
    Journal Article Conference Proceeding
  17. 17
  18. 18

    Cyclic urea derivatives as potent NK1 selective antagonists by SHUE, Ho-Jane, XIAO CHEN, PIWINSKI, John J, DUFFY, Ruth A, LACHOWICZ, Jean E, COFFIN, Vicki L, FEI LIU, NOMEIR, Amin A, MORGAN, Cynthia A, VARTY, Geoffrey B, SHIH, Neng-Yang, BLYTHIN, David J, PALIWAL, Sunil, LING LIN, DANLIN GU, SCHWERDT, John H, SHAH, Sapna, REICHARD, Gregory A

    Published in Bioorganic & medicinal chemistry letters (01-09-2005)
    “…A series of novel five- and six-membered ring urea derivatives have been described as potent and selective NK1 receptor antagonists. Several compounds in this…”
    Get full text
    Journal Article
  19. 19

    Validation of a rapid microtiter plate assay to conduct cytochrome P450 2D6 enzyme inhibition studies by Palamanda, Jairam R, Favreau, Leonard, Lin, Chin-chung, Nomeir, Amin A

    Published in Drug discovery today (01-10-1998)
    “…Cytochrome P450 (CYP) inhibition studies are often performed on new chemical entities during the drug discovery stage. However, advances in combinatorial…”
    Get full text
    Journal Article
  20. 20